{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:24:58Z","timestamp":1772166298169,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-024-03267-9","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T04:16:52Z","timestamp":1735964212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heparin rebound in patients undergoing off-pump coronary artery bypass grafting surgery: a single-center retrospective study"],"prefix":"10.1186","volume":"20","author":[{"given":"Fei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-shan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-quan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-tai","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Evidence in Cardiovascular Anesthesia (EICA) Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"issue":"4","key":"3267_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1053\/j.jvca.2022.12.019","volume":"37","author":"ME Stone","year":"2023","unstructured":"Stone ME, Vespe MW. Heparin rebound: an In-Depth review. J Cardiothorac Vasc Anesth. 2023;37(4):601\u201312.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"3","key":"3267_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00000542-199203000-00012","volume":"76","author":"GP Gravlee","year":"1992","unstructured":"Gravlee GP, Rogers AT, Dudas LM, Taylor R, Roy RC, Case LD, Triscott M, Brown CW, Mark LJ, Cordell AR. Heparin management protocol for cardiopulmonary bypass influences postoperative heparin rebound but not bleeding. Anesthesiology. 1992;76(3):393\u2013401.","journal-title":"Anesthesiology"},{"issue":"5","key":"3267_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1445-2197.1995.tb00648.x","volume":"65","author":"P Subramaniam","year":"1995","unstructured":"Subramaniam P, Skillington P, Tatoulis J. Heparin-rebound in the early postoperative phase following cardiopulmonary bypass. Aust N Z J Surg. 1995;65(5):331\u20133.","journal-title":"Aust N Z J Surg"},{"issue":"2","key":"3267_CR4","first-page":"337","volume":"124","author":"S Gollub","year":"1967","unstructured":"Gollub S. Heparin rebound in open heart surgery. Surg Gynecol Obstet. 1967;124(2):337\u201346.","journal-title":"Surg Gynecol Obstet"},{"issue":"5","key":"3267_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0022-5223(19)41741-8","volume":"67","author":"N Ellison","year":"1974","unstructured":"Ellison N, Beatty CP, Blake DR, Wurzel HA, MacVaugh H 3rd. Heparin rebound. Studies in patients and volunteers. J Thorac Cardiovasc Surg. 1974;67(5):723\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"3267_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1055\/s-2007-1004382","volume":"11","author":"EF Mammen","year":"1985","unstructured":"Mammen EF, Koets MH, Washington BC, Wolk LW, Brown JM, Burdick M, Selik NR, Wilson RF. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost. 1985;11(3):281\u201392.","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"3267_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/1053-0770(91)90278-2","volume":"5","author":"AH Kuitunen","year":"1991","unstructured":"Kuitunen AH, Salmenper\u00e4 MT, Heinonen J, Rasi VP, Myllyl\u00e4 G. Heparin rebound: a comparative study of protamine chloride and protamine sulfate in patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 1991;5(3):221\u20136.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"3267_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0022-5223(19)40382-6","volume":"70","author":"F Bachmann","year":"1975","unstructured":"Bachmann F, McKenna R, Cole ER, Najafi H. The hemostatic mechanism after open-heart surgery. I. studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J Thorac Cardiovasc Surg. 1975;70(1):76\u201385.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3267_CR9","doi-asserted-by":"publisher","first-page":"965648","DOI":"10.3389\/fcvm.2022.965648","volume":"9","author":"C Wang","year":"2022","unstructured":"Wang C, Jiang Y, Song Y, Wang Q, Tian R, Wang D, Dong N, Jiang X, Chen S, Chen X. Off-pump or on-pump coronary artery bypass at 30 days: a propensity matched analysis. Front Cardiovasc Med. 2022;9:965648.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"3267_CR10","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0096-5588(20)30574-2","volume":"32","author":"DB EFFLER","year":"1956","unstructured":"Effler DB, Groves LK, Kolff WJ, Sones FM Jr. Disposable membrane oxygenator (heart-lung machine) and its use in experimental surgery. J Thorac Surg. 1956;32(5):620\u20139.","journal-title":"J Thorac Surg"},{"issue":"1","key":"3267_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/0003-4975(94)91103-7","volume":"58","author":"GP Gravlee","year":"1994","unstructured":"Gravlee GP, Arora S, Lavender SW, Mills SA, Hudspeth AS, Cordell AR, James RL, Brockschmidt JK, Stuart JJ. Predictive value of blood clotting tests in cardiac surgical patients. Ann Thorac Surg. 1994;58(1):216\u201321.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"3267_CR12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1053\/j.jvca.2012.10.020","volume":"27","author":"A Galeone","year":"2013","unstructured":"Galeone A, Rotunno C, Guida P, Bisceglie A, Rubino G, Schinosa Lde L, Paparella D. Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery. J Cardiothorac Vasc Anesth. 2013;27(5):853\u20138.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"3267_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1213\/00000539-198805000-00010","volume":"67","author":"GP Gravlee","year":"1988","unstructured":"Gravlee GP, Case LD, Angert KC, et al. Variability of the activated coagulation time. Anesth Analg. 1988;67:469\u201372.","journal-title":"Anesth Analg"},{"issue":"4","key":"3267_CR14","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1213\/00000539-199810000-00008","volume":"87","author":"T Mochizuki","year":"1998","unstructured":"Mochizuki T, Olson PJ, Szlam F, Ramsay JG, Levy JH. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg. 1998;87(4):781\u20135.","journal-title":"Anesth Analg"},{"issue":"4","key":"3267_CR15","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/biom11040544","volume":"11","author":"R Gindele","year":"2021","unstructured":"Gindele R, P\u00e9nzes-Daku K, Balogh G, K\u00e1llai J, Bog\u00e1ti R, B\u00e9csi B, Erd\u0151di F, Katona \u00c9, Bereczky Z. Investigation of the differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua mutations by biochemical and in Silico methods. Biomolecules. 2021;11(4):544.","journal-title":"Biomolecules"},{"issue":"3","key":"3267_CR16","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0003-4975(94)90752-8","volume":"58","author":"K Hashimoto","year":"1994","unstructured":"Hashimoto K, Yamagishi M, Sasaki T, Nakano M, Kurosawa H. Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation. Ann Thorac Surg. 1994;58(3):799\u2013804. discussion 804-5.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"3267_CR17","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.xphs.2018.01.008","volume":"107","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhao J, Yu Y, Liu X, Lin L, Zhang F, Linhardt RJ. Antithrombin III-Binding site analysis of low-molecular-weight heparin fractions. J Pharm Sci. 2018;107(5):1290\u20135.","journal-title":"J Pharm Sci"},{"key":"3267_CR18","first-page":"112659","volume":"135","author":"X Fu","year":"2022","unstructured":"Fu X, Lei T, Li SJ, Liu YF, Peng J, Ning JP. Construction of novel antiplatelet modified polyethersulfone membrane and study into its blood compatibility. Mater Sci Eng C Mater Biol Appl. 2022;135:112659.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"6","key":"3267_CR19","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/j.xphs.2016.03.037","volume":"105","author":"Y Guan","year":"2016","unstructured":"Guan Y, Xu X, Liu X, Sheng A, Jin L, Linhardt RJ, Chi L. Comparison of low-molecular-weight heparins prepared from bovine lung heparin and Porcine Intestine Heparin. J Pharm Sci. 2016;105(6):1843\u201350.","journal-title":"J Pharm Sci"},{"issue":"1","key":"3267_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S1053-0770(97)90247-0","volume":"11","author":"DJ Murray","year":"1997","unstructured":"Murray DJ, Brosnahan WJ, Pennell B, Kapalanski D, Weiler JM, Olson J. Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays. J Cardiothorac Vasc Anesth. 1997;11(1):24\u20138.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"6","key":"3267_CR21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/0049-3848(94)90174-0","volume":"75","author":"ME Carr Jr","year":"1994","unstructured":"Carr ME Jr, Carr SL. At high heparin concentrations, protamine concentrations which reverse heparin anticoagulant effects are insufficient to reverse heparin anti-platelet effects. Thromb Res. 1994;75(6):617\u201330.","journal-title":"Thromb Res"},{"issue":"8","key":"3267_CR22","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1177\/02676591231199218","volume":"39","author":"M Rijpkema","year":"2024","unstructured":"Rijpkema M, Vlot EA, Stehouwer MC, Bruins P. Does heparin rebound lead to postoperative blood loss in patients undergoing cardiac surgery with cardiopulmonary bypass? Perfusion. 2024;39(8):1491\u2013515.","journal-title":"Perfusion"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-03267-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-024-03267-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-03267-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T05:03:48Z","timestamp":1735967028000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-024-03267-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3267"],"URL":"https:\/\/doi.org\/10.1186\/s13019-024-03267-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4577442\/v1","asserted-by":"object"}]},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by our institutional review board (Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences), which waived the requirement for individual patient consent because only routine patient data were used for this retrospective analysis. All experiments were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}